Dr. Mujahid A. Rizvi, MD

Dr. Rizvi practices at Asante Rogue Regional Medical Center in Medford, Oregon, part of Asante Health System.

Dr. Rizvi's NPI, 1699727891, was assigned on May 16, 2006. Dr. Rizvi holds Oregon license MD26359.

Dr. Rizvi's primary practice is Asante Rogue Regional Medical Center, at 2825 E Barnett Road, Medford, OR 97504 in Jackson County. The practice phone is (541) 789-7000.

Dr. Rizvi's primary practice is Asante Rogue Regional Medical Center in Medford, Oregon, part of Asante Health System. Dr. Rizvi is also affiliated with Sky Lakes Medical Center. The medical group on file is Asante Rogue Regional Medical Center. Dmand AI also links Dr. Rizvi to 4 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account. Dr. Rizvi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rizvi is licensed in Oregon.

CMS data shows 1,227 Medicare services from Dr. Rizvi across 8 procedure codes in 2024, for 290 Medicare patients. Medicare paid $59,513 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 290 Medicare patients who saw Dr. Rizvi in 2024. The largest group is 75 to 84, with 124 patients. 70% of them have high blood pressure, and 67% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 73, with 55% women.

In 2024, Dr. Rizvi wrote 826 Medicare Part D claims for 161 patients. 74% of them were for generic drugs. CMS names the drug for 558 of them, across 22 drugs with 11 or more claims each, at $1,241,045 in total drug cost. In 2023, CMS named 720 claims across 29 drugs.

Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rizvi as offering telehealth.

CMS Open Payments shows 46 general payments to Dr. Rizvi from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,455.